DUA U of T and Merck Canada partner to advance and share vaccine knowledge and research A $3-million contribution from Merck Canada Inc. to the Dalla Lana School of Public Health’s Centre for Vaccine Preventable Diseases reinforces U of T’s role as a leader in the advancement of immunization and vaccine science (photo by Johnny Guatto) As Canada marks National Immunization Awareness Week, a new investment from Merck Canada to the University of Toronto’s Centre for Vaccine Preventable Diseases at the Dalla Lana School of Public Health (DLSPH) will support research, education and knowledge translation around vaccine science and help communicate the importance of immunization as a cornerstone of public health.